PATENT CLAIM ANALYSIS

Application Number: 15893261
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-11
Patent Classification: ["424", "186100"]

Abstract:
Novel nanoparticle fusion proteins comprising proteins or peptides fused to Dps (DNA binding protein from starved cells) proteins are provided which bring forth distinct advantages for development of new and improved vaccines, diagnostic tests, and other biomedical products.

Claim (Index 1):
A Dps fusion protein comprising two proteins or peptides fused separately and simultaneously to the N-terminus and C-terminus of Dps, wherein said Dps fusion protein is capable of self-assembly into nanoparticles and said proteins or peptides are presented on the outer surface of said Dps fusion protein.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 88.0
- Lexical Diversity: 1.10256
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14967729', '13520253', '11410572', '15289106', '12717804']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7426872471643531
- 35 USC 102 Novelty (BERT): 0.6406313811354304
- Combined Prediction Score: 0.7324816605614608
- Mean Citation Score: 404.35247
- Max Citation Score: 592.2097
- Similarity Product: 590.5428719491658

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test